LINCOLN NATIONAL CORP Stock Compensation Disclosure
| For the Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Stock options | $ | 2 | $ | 5 | $ | 8 | |||||||||||
| Performance shares | 23 | 8 | 12 | ||||||||||||||
| RSUs | 53 | 51 | 41 | ||||||||||||||
| Total | $ | 78 | $ | 64 | $ | 61 | |||||||||||
| Recognized tax benefit | $ | 13 | $ | 11 | $ | 9 | |||||||||||
| For the Years Ended December 31, | |||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||||||||||||||||||||
| Expense | Weighted-Average Period | Expense | Weighted-Average Period | Expense | Weighted-Average Period | ||||||||||||||||||||||||||||||
| Stock options | $ | – | 0.0 | $ | 3 | 0.8 | $ | 9 | 0.8 | ||||||||||||||||||||||||||
| Performance shares | 25 | 1.7 | 20 | 1.5 | 21 | 1.3 | |||||||||||||||||||||||||||||
| RSUs | 41 | 1.1 | 40 | 1.4 | 54 | 1.6 | |||||||||||||||||||||||||||||
| Total unrecognized stock-based | |||||||||||||||||||||||||||||||||||
| incentive compensation expense | $ | 66 | $ | 63 | $ | 84 | |||||||||||||||||||||||||||||
| For the Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Weighted-average fair value per option granted | $ | 9.60 | $ | 9.53 | $ | 11.64 | |||||||||||
| Weighted-average assumptions: | |||||||||||||||||
| Dividend yield | 3.7 | % | 4.4 | % | 4.1 | % | |||||||||||
| Expected volatility | 40.9 | % | 54.5 | % | 48.1 | % | |||||||||||
Risk-free interest rate (1) | 4.0 | % | 4.3 | % | 3.8-4.1% | ||||||||||||
| Expected life (in years) | 4.1 | 4.1 | 5.8 | ||||||||||||||
| Shares | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Term | Aggregate Intrinsic Value | ||||||||||||||||||||
| Outstanding as of December 31, 2024 | 3,414,454 | $ | 54.90 | ||||||||||||||||||||
| Granted | – | – | |||||||||||||||||||||
| Exercised | (430,947) | 35.16 | |||||||||||||||||||||
| Forfeited or expired | (304,873) | 57.24 | |||||||||||||||||||||
| Outstanding as of December 31, 2025 | 2,678,634 | $ | 57.82 | 4.5 | $ | 6 | |||||||||||||||||
Vested or expected to vest as of December 31, 2025 (1) | 2,641,061 | $ | 58.14 | 4.4 | $ | 5 | |||||||||||||||||
| Exercisable as of December 31, 2025 | 2,446,292 | $ | 59.79 | 4.2 | $ | 3 | |||||||||||||||||
| Shares | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Term | Aggregate Intrinsic Value | ||||||||||||||||||||
| Outstanding as of December 31, 2024 | 92,455 | $ | 41.12 | ||||||||||||||||||||
| Granted | 12,453 | 34.46 | |||||||||||||||||||||
| Exercised | (23,598) | 25.26 | |||||||||||||||||||||
| Forfeited or expired | (7,538) | 25.07 | |||||||||||||||||||||
| Outstanding as of December 31, 2025 | 73,772 | $ | 46.71 | 1.8 | $ | 1 | |||||||||||||||||
Vested or expected to vest as of December 31, 2025 (1) | 73,026 | $ | 46.88 | 1.8 | $ | 1 | |||||||||||||||||
| Exercisable as of December 31, 2025 | 71,286 | $ | 47.28 | 1.7 | $ | – | |||||||||||||||||
| Shares | Weighted-Average Grant Date Fair Value | ||||||||||
Outstanding as of December 31, 2024 (1) | 1,594,032 | $ | 40.74 | ||||||||
| Granted | 758,608 | 43.73 | |||||||||
| Vested | – | – | |||||||||
| Forfeited | (65,699) | 37.26 | |||||||||
Performance adjustment (2) | (317,984) | 70.77 | |||||||||
Outstanding as of December 31, 2025 (1) | 1,968,957 | $ | 37.16 | ||||||||
| Shares | Weighted-Average Grant Date Fair Value | ||||||||||||||||
| Outstanding as of December 31, 2024 | 3,776,233 | $ | 34.24 | ||||||||||||||
| Granted | 1,830,408 | 38.30 | |||||||||||||||
| Vested | (819,272) | 53.10 | |||||||||||||||
| Forfeited | (263,694) | 31.99 | |||||||||||||||
| Outstanding as of December 31, 2025 | 4,523,675 | $ | 32.53 | ||||||||||||||
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.